| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.028 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |